Stepan Company (SCL) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
Despite some positive aspects like increased dividends and specialty products growth, the overall sentiment is negative due to significant declines in adjusted net income and EBITDA, margin pressures, and unclear management responses regarding future plans. The company is also dealing with challenging raw material costs and competitive pressures. The market cap suggests a moderate reaction, leading to a likely negative stock price movement of -2% to -8% over the next two weeks.
Key Financial Performance
Adjusted EBITDA (Year-to-Date) $165 million, a 9% increase year-over-year. Growth was restrained by significant increases in oleochemical raw material prices and higher start-up costs at the Pasadena, Texas facility.
Third Quarter Adjusted EBITDA $56 million, a 6% increase year-over-year. Growth was driven by strong specialty product results and the non-recurrence of expenses from a 2024 fraud event, but offset by higher raw material costs and start-up expenses.
Specialty Products Adjusted EBITDA Increased by 113% year-over-year, driven by favorable order timing within the pharmaceutical business.
Polymers Adjusted EBITDA Decreased by 4% year-over-year due to lower unit margins and unfavorable mix, despite an 8% volume growth.
Surfactants Adjusted EBITDA Decreased by 14% year-over-year, impacted by a 2% volume contraction, higher start-up expenses at the Pasadena site, and increased raw material costs.
Total Company Sales Volumes Grew by 1% year-over-year. Polymers volumes increased by 8%, NCT product line volumes grew by 26%, while Surfactants volumes declined by 2%.
Adjusted Net Income $10.9 million, a 54% decrease year-over-year. The decline was due to a higher effective tax rate, higher interest net, and higher depreciation, none of which had a cash impact.
Free Cash Flow $40 million, driven by reduced working capital and disciplined capital spending.
Dividends Paid $8.7 million during the quarter, representing a 2.6% increase in the dividend.
Surfactants Net Sales $422.4 million, a 10% increase year-over-year. Growth was driven by improved product and customer mix and the pass-through of higher raw material costs, despite a 2% volume decline.
Polymers Net Sales $143.9 million, a 4% decrease year-over-year. Selling prices decreased by 14% due to lower raw material costs and competitive pressures, while volumes increased by 8%.
Specialty Products Net Sales $24 million, a 68% increase year-over-year, primarily due to higher sales volumes.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Pasadena, Texas facility: The facility is fully operational and ramping up production. It has produced 41 different products to date and is expected to achieve full contribution rate in 2026.
Spray-foam end market: Introduced a new product in this growing market, enhancing growth in the North America Rigid Polyol business.
Crop productivity and oilfield businesses: Strong growth observed in these segments.
North America Rigid Polyol business: Continued year-over-year growth, supported by new product introduction.
Operational reliability improvements: Investments in the Millville site have improved operational reliability.
Supply chain savings: Expected from the operational Pasadena facility.
End market diversification: Focus on diversifying end markets, with strong growth in crop productivity and oilfield businesses.
Customer acquisition: Added over 350 new customers, focusing on Tier 2 and Tier 3 customers as a profitable growth channel.
Global footprint optimization: On track to close the sale of the Philippines site in Q4 2025 and analyzing further optimization opportunities.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Oleochemical raw material cost inflation: Significantly higher oleochemical raw material costs are impacting surfactant margins, leading to financial pressures.
Pasadena facility start-up costs: Higher start-up expenses at the new Pasadena, Texas facility are negatively affecting earnings and margins.
Global commodity consumer product demand: Lower demand within the global commodity consumer products end market is reducing sales volumes and impacting financial performance.
European Rigid Polyol volumes: European Rigid Polyol volumes are being negatively impacted by macroeconomic uncertainties and low construction activity.
Higher effective tax rate: The recently enacted U.S. tax law has resulted in a higher effective tax rate, reducing net income.
Competitive pressures in Polymers: Selling prices in the Polymers segment have decreased due to competitive pressures, impacting margins.
Unfavorable product mix in Polymers: Unfavorable mix in the Polymers segment is contributing to lower EBITDA despite volume growth.
Tariff and market uncertainties: Ongoing market and tariff uncertainties are creating challenges for strategic planning and operational execution.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Effective Tax Rate: The company is forecasting a return to its normal effective tax rate range of 24% to 26%.
Free Cash Flow: The company remains optimistic about delivering positive free cash flow for the full year 2025.
Pasadena Facility: The new Pasadena site is fully operational and ramping up production. Full contribution rate of the plant is expected to be achieved in 2026. The facility is expected to enable volume growth in the alkoxylation product line and supply chain savings.
Surfactant Business: The company expects continued growth in key strategic end markets, including crop productivity and oilfield businesses.
Polymers Demand: Demand is expected to improve as market certainty increases and innovation and growth plans are executed.
Philippines Site Sale: The company remains on track to close the sale of its site in the Philippines in the fourth quarter of 2025.
Adjusted EBITDA: The company remains optimistic about delivering full-year adjusted EBITDA growth in 2025.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividend Payment: During the third quarter of 2025, the company paid $8.7 million in dividends to shareholders.
Dividend Increase: The Board of Directors declared a quarterly cash dividend on Stepan common stock of $0.395 per share, payable on December 15, 2025. This represents a 2.6% increase in the dividend.
Dividend History: Stepan has paid and increased its dividend for 58 consecutive years.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Where are we in the process of recovering the oleochemicals cost run-up in surfactants?
A:Coconut oil prices have increased by 70% from $1,500 per metric ton in 2024 to $2,500 in 2025, peaking at $3,000. Prices are now coming down, and the company has implemented a price increase in North America as of October 1. The goal is to recover margins by 2026.
Q:Does the decrease in raw material costs make it more challenging to get the pricing needed?
A:The company aims to balance volumes and margins to maximize net income and remain competitive. They will not lose market share and will continue managing this balance effectively.
Q:What are the longer-term goals for the Surfactants segment margin?
A:The company believes the Surfactants segment can achieve healthy double-digit EBITDA margins in the future as they grow in functional markets like agrochemical, oilfield, construction, and industrial solutions. Current EBITDA margins are close to 10%, restrained by investments in Pasadena and oleochemical impacts.
Q:Is there pent-up demand in the commercial roofing and insulation space, and could lower interest rates stimulate activity?
A:There is significant pent-up demand for reroofing projects due to construction from the early 2000s. PIR insulation is the preferred choice for flat roof projects. Lower interest rates and reduced inflation could stimulate construction activity by 2026.
Q:Will recovery in demand lead to recovery in unit margins for the Polymers business?
A:The company has modestly grown EBITDA despite sales being down. They aim to grow volumes and improve margins through scale, but no significant margin increase is planned. Margins are slightly improving despite challenges in Europe.
Q:What actions are being considered to optimize the company's footprint?
A:The company is committed to balanced EBITDA and net income growth through productivity, asset rationalization, and top-line growth. They have announced the Philippines asset sale and plan more announcements in the future to address overcapacity in the chemical industry.
Q:How much growth potential is there in the spray foam market, and could Europe see growth if the environment improves?
A:The spray foam market has significant growth potential, especially in the U.S., with future opportunities in Europe. Growth in Europe depends on improved construction activity and energy conservation trends, but it is not expected in the short term.
Q:What is the demand outlook for the Surfactants segment, particularly in laundry and cleaning markets?
A:Demand in laundry and cleaning markets is evolving, with consumers switching to lower active products. However, active levels cannot go significantly lower for product effectiveness. The company is optimistic about demand in 2026 and 2027.
Q:How sustainable are the recent volume growth levels in the Specialty Products business?
A:The Specialty Products business has shown strong performance, with 26% volume growth in the MCT product line. The company is pleased with the results and plans to continue investing to sustain and maximize returns.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on future asset rationalization actions, stating only that announcements will be made when ready. Additionally, while optimistic about future growth in Europe for spray foam and construction activity, they did not provide concrete timelines or detailed plans.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
America commodity
America volume
Anhydride Global
Chief Financial
China volume
Financial Officer
Global Specialty
Mr VP
North America
Officer Stepan
Officer comment
Polymers result
President Chief
Surfactant Pasadena
Surfactants Polymers
VP Chief
capital spending
commodity PA
commodity consumer
consumer product
demand commodity
depreciation
dividend Stepan
flow capital
material price
month
oilfield
order
product end
product market
rate tax
reduction capital
tax law
tax rate
timing
volume Specialty
volume demand
SCL Transcript
Stepan Company (SCL) Q1 2026 Earnings Call Transcript
Unknown4-28
The earnings call lacked specific financial figures and updates, indicating a lack of transparency. The mention of risks in foreign operations and economic conditions adds to investor concerns. The absence of discussion on shareholder returns and lack of clear management responses in the Q&A further contribute to a negative sentiment. Given the small-cap nature of the company, these factors are likely to result in a negative stock price movement over the next two weeks.
Stepan Company (SCL) Q4 2025 Earnings Call Transcript
Unknown2-23
The earnings call summary shows mixed signals: a decrease in net income but increased EBITDA, and optimism for future growth. The Q&A highlights concerns about inflation and oleochemical impacts, but also mentions cost optimization and strategic growth initiatives. The market cap suggests moderate sensitivity to news. Overall, the sentiment is neutral, as positive long-term guidance and strategic initiatives balance out short-term financial challenges and uncertainties.
Stepan Company (SCL) Q3 2025 Earnings Call Transcript
Unknown10-29
Despite some positive aspects like increased dividends and specialty products growth, the overall sentiment is negative due to significant declines in adjusted net income and EBITDA, margin pressures, and unclear management responses regarding future plans. The company is also dealing with challenging raw material costs and competitive pressures. The market cap suggests a moderate reaction, leading to a likely negative stock price movement of -2% to -8% over the next two weeks.
Stepan Company (SCL) Q2 2025 Earnings Call Transcript
Unknown7-30
The earnings call summary presents mixed signals: strong growth in polymers and specialty products, yet challenges in surfactants and negative free cash flow. The Q&A reveals concerns about raw material costs and asset optimization, but also highlights potential growth from pricing adjustments and new initiatives. The market cap suggests moderate volatility, so the stock price is likely to remain stable, with a neutral sentiment in the short term.
SCL Slides
SCL Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
